Target intelligence / Profile preview

Elongation factor for RNA polymerase II 2 pseudogene 1 (ELL2P1)

Target
ELL2P1
Molecular classification
Pseudogene
01

Overview

The entry "Elongation factor for RNA polymerase II 2 pseudogene 1 (ELL2P1)" refers to a pseudogene and does not encode a functional protein or receptor. Its name suggests it is related to the functional gene ELL2, which encodes a general transcription elongation factor involved in increasing the rate of RNA polymerase II transcription by suppressing pausing on DNA templates[2][1]. The functional ELL2 protein acts directly on the ternary elongation complex and is classified as a transcription elongation factor, but ELL2P1 itself plays no direct biological or therapeutic role, has no molecular function, drug interactions, or disease implications known in the literature. If a functional elongation factor is the intended target, information should pertain to ELL2 (Elongation factor for RNA polymerase II 2) instead. In summary, the name ELL2P1 describes a pseudogene and not a functional target or receptor. Any structured information should be mapped to the functional gene ELL2 in cases where a transcription elongation factor is desired, not the pseudogene ELL2P1.

Other names
ELL2P1Elongation factor for RNA polymerase II 2 pseudogene 1
02

Mechanism of action

None (not functional)

03

Biological functions

None (as a pseudogene)
04

Disease associations

None (no known disease associations for the pseudogene itself)
05

Safety considerations

None (not a therapeutic target)
06

Interacting drugs

None (as a pseudogene, it does not interact with drugs)
07

Biomarkers

None

Beyond the preview

Go deeper on Elongation factor for RNA polymerase II 2 pseudogene 1 (ELL2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongation factor for RNA polymerase II 2 pseudogene 1 (ELL2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call